These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 11113199)

  • 21. Beta 1 integrin- and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides.
    Wilson KE; Li Z; Kara M; Gardner KL; Roberts DD
    J Immunol; 1999 Oct; 163(7):3621-8. PubMed ID: 10490955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of ERKs and mitogen- and stress-activated protein kinase in UVC-induced phosphorylation of ATF2 in JB6 cells.
    Zhu F; Zhang Y; Bode AM; Dong Z
    Carcinogenesis; 2004 Oct; 25(10):1847-52. PubMed ID: 15192015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
    Roux PP; Richards SA; Blenis J
    Mol Cell Biol; 2003 Jul; 23(14):4796-804. PubMed ID: 12832467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extremely low-dose ionizing radiation causes activation of mitogen-activated protein kinase pathway and enhances proliferation of normal human diploid cells.
    Suzuki K; Kodama S; Watanabe M
    Cancer Res; 2001 Jul; 61(14):5396-401. PubMed ID: 11454682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA aptamers as pathway-specific MAP kinase inhibitors.
    Seiwert SD; Stines Nahreini T; Aigner S; Ahn NG; Uhlenbeck OC
    Chem Biol; 2000 Nov; 7(11):833-43. PubMed ID: 11094337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dual-specificity protein phosphatase DUSP5.
    Mandl M; Slack DN; Keyse SM
    Mol Cell Biol; 2005 Mar; 25(5):1830-45. PubMed ID: 15713638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear shuttling of mitogen-activated protein (MAP) kinase (extracellular signal-regulated kinase (ERK) 2) was dynamically controlled by MAP/ERK kinase after antigen stimulation in RBL-2H3 cells.
    Furuno T; Hirashima N; Onizawa S; Sagiya N; Nakanishi M
    J Immunol; 2001 Apr; 166(7):4416-21. PubMed ID: 11254696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical and molecular analysis of the interaction between ERK2 MAP kinase and hypoxia inducible factor-1α.
    Karapetsas A; Giannakakis A; Pavlaki M; Panayiotidis M; Sandaltzopoulos R; Galanis A
    Int J Biochem Cell Biol; 2011 Nov; 43(11):1582-90. PubMed ID: 21807114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered regulation of ERK1b by MEK1 and PTP-SL and modified Elk1 phosphorylation by ERK1b are caused by abrogation of the regulatory C-terminal sequence of ERKs.
    Yung Y; Yao Z; Aebersold DM; Hanoch T; Seger R
    J Biol Chem; 2001 Sep; 276(38):35280-9. PubMed ID: 11463794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational analysis of ribosomal S6 kinase 2 shows differential regulation of its kinase activity from that of ribosomal S6 kinase 1.
    Phin S; Kupferwasser D; Lam J; Lee-Fruman KK
    Biochem J; 2003 Jul; 373(Pt 2):583-91. PubMed ID: 12713446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway.
    Lo LW; Cheng JJ; Chiu JJ; Wung BS; Liu YC; Wang DL
    J Cell Physiol; 2001 Sep; 188(3):304-12. PubMed ID: 11473356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
    Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
    Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions.
    Whitehurst AW; Robinson FL; Moore MS; Cobb MH
    J Biol Chem; 2004 Mar; 279(13):12840-7. PubMed ID: 14707138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stress- and mitogen-induced phosphorylation of the synapse-associated protein SAP90/PSD-95 by activation of SAPK3/p38gamma and ERK1/ERK2.
    Sabio G; Reuver S; Feijoo C; Hasegawa M; Thomas GM; Centeno F; Kuhlendahl S; Leal-Ortiz S; Goedert M; Garner C; Cuenda A
    Biochem J; 2004 May; 380(Pt 1):19-30. PubMed ID: 14741046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel membrane-targeted ERK1 and ERK2 chimeras which act as dominant negative, isotype-specific mitogen-activated protein kinase inhibitors of Ras-Raf-mediated transcriptional activation of c-fos in NIH 3T3 cells.
    Hochholdinger F; Baier G; Nogalo A; Bauer B; Grunicke HH; Uberall F
    Mol Cell Biol; 1999 Dec; 19(12):8052-65. PubMed ID: 10567531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel point mutations in ERK2 that selectively disrupt binding to MEK1.
    Robinson FL; Whitehurst AW; Raman M; Cobb MH
    J Biol Chem; 2002 Apr; 277(17):14844-52. PubMed ID: 11823456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrin-mediated adhesion regulates ERK nuclear translocation and phosphorylation of Elk-1.
    Aplin AE; Stewart SA; Assoian RK; Juliano RL
    J Cell Biol; 2001 Apr; 153(2):273-82. PubMed ID: 11309409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dominant negative Ras mutant, N17Ras, can inhibit signaling independently of blocking Ras activation.
    Stewart S; Guan KL
    J Biol Chem; 2000 Mar; 275(12):8854-62. PubMed ID: 10722731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.